Literature DB >> 26807405

Is spread through alveolar spaces, the newly recognized pattern of invasion, a potential game changer in lung adenocarcinoma?

Sarina Bains1, Prasad S Adusumilli1.   

Abstract

Entities:  

Year:  2015        PMID： 26807405      PMCID： PMC4701525          DOI： 10.3978/j.issn.2305-5839.2015.09.43

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.

Authors:  Judith van Loon; Christian Siedschlag; Joep Stroom; Hans Blauwgeers; Robert-Jan van Suylen; Joost Knegjens; Maddalena Rossi; Angela van Baardwijk; Liesbeth Boersma; Houke Klomp; Wouter Vogel; Sjaak Burgers; Kenneth Gilhuijs
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-23       Impact factor: 7.038

2.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Authors:  Jun-ichi Nitadori; Adam J Bograd; Kyuichi Kadota; Camelia S Sima; Nabil P Rizk; Eduardo A Morales; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  J Natl Cancer Inst       Date:  2013-08-07       Impact factor: 13.506

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Camelia S Sima; Hideki Ujiie; Nabil P Rizk; David R Jones; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

5.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Authors:  Akihiko Yoshizawa; Noriko Motoi; Gregory J Riely; Cami S Sima; William L Gerald; Mark G Kris; Bernard J Park; Valerie W Rusch; William D Travis
Journal:  Mod Pathol       Date:  2011-01-21       Impact factor: 7.842

6.  Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.

Authors:  Morihito Okada; Teruaki Koike; Masahiko Higashiyama; Yasushi Yamato; Ken Kodama; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

7.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

8.  Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis.

Authors:  Maristela L Onozato; Alexandra E Kovach; Beow Y Yeap; Vicente Morales-Oyarvide; Veronica E Klepeis; Swathi Tammireddy; Rebecca S Heist; Eugene J Mark; Dora Dias-Santagata; A John Iafrate; Yukako Yagi; Mari Mino-Kenudson
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

9.  A role of three-dimensional (3D) reconstruction in the classification of lung adenocarcinoma.

Authors:  Maristela L Onozato; Veronica E Klepeis; Yukako Yagi; Mari Mino-Kenudson
Journal:  Stud Health Technol Inform       Date:  2012

10.  Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.

Authors:  Hideki Ujiie; Kyuichi Kadota; Jamie E Chaft; Daniel Buitrago; Camelia S Sima; Ming-Ching Lee; James Huang; William D Travis; Nabil P Rizk; Charles M Rudin; David R Jones; Prasad S Adusumilli
Journal:  J Clin Oncol       Date:  2015-08-10       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.